Argus starts Keurig Dr Pepper at Buy on ‘compelling’ growth/value profile

As previously reported, Argus initiated coverage of Keurig Dr Pepper (KDP) with a Buy rating and $40 price target Given its large-scale retail distribution and broad selection of products that appeal to a variety of tastes and times of day, Keurig Dr. Pepper provides investors an opportunity to profit from the growing domestic non-alcoholic beverage market, the analyst tells investors in a research note. The stock also offers a compelling combination of growth and value, the management’s growth targets are reasonable and beatable, and shares trade at a discount to the peer group on price to sales and price to earnings basis, Argus adds.